Literature DB >> 10856237

A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.

M Frödin1, C J Jensen, K Merienne, S Gammeltoft.   

Abstract

The 90 kDa ribosomal S6 kinase-2 (RSK2) is a growth factor-stimulated protein kinase with two kinase domains. The C-terminal kinase of RSK2 is activated by ERK-type MAP kinases, leading to autophosphorylation of RSK2 at Ser386 in a hydrophobic motif. The N-terminal kinase is activated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) through phosphorylation of Ser227, and phosphorylates the substrates of RSK. Here, we identify Ser386 in the hydrophobic motif of RSK2 as a phosphorylation-dependent docking site and activator of PDK1. Treatment of cells with growth factor induced recruitment of PDK1 to the Ser386-phosphorylated hydrophobic motif and phosphorylation of RSK2 at Ser227. A RSK2-S386K mutant showed no interaction with PDK1 or phosphorylation at Ser227. Interaction with Ser386-phosphorylated RSK2 induced autophosphorylation of PDK1. Addition of a synthetic phosphoSer386 peptide (RSK2(373-396)) increased PDK1 activity 6-fold in vitro. Finally, mutants of RSK2 and MSK1, a RSK-related kinase, with increased affinity for PDK1, were constitutively active in vivo and phosphorylated histone H3. Our results suggest a novel regulatory mechanism based on phosphoserine-mediated recruitment of PDK1 to RSK2, leading to coordinated phosphorylation and activation of PDK1 and RSK2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856237      PMCID: PMC203368          DOI: 10.1093/emboj/19.12.2924

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1.

Authors:  C J Jensen; M B Buch; T O Krag; B A Hemmings; S Gammeltoft; M Frödin
Journal:  J Biol Chem       Date:  1999-09-17       Impact factor: 5.157

2.  Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B.

Authors:  D Stokoe; L R Stephens; T Copeland; P R Gaffney; C B Reese; G F Painter; A B Holmes; F McCormick; P T Hawkins
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

3.  The signal-dependent coactivator CBP is a nuclear target for pp90RSK.

Authors:  T Nakajima; A Fukamizu; J Takahashi; F H Gage; T Fisher; J Blenis; M R Montminy
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

4.  Identification of serine 380 as the major site of autophosphorylation of Xenopus pp90rsk.

Authors:  T A Vik; J W Ryder
Journal:  Biochem Biophys Res Commun       Date:  1997-06-18       Impact factor: 3.575

5.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

6.  Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome.

Authors:  E Trivier; D De Cesare; S Jacquot; S Pannetier; E Zackai; I Young; J L Mandel; P Sassone-Corsi; A Hanauer
Journal:  Nature       Date:  1996-12-12       Impact factor: 49.962

7.  Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.

Authors:  Y Zhao; C Bjorbaek; D E Moller
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

8.  Evidence for two catalytically active kinase domains in pp90rsk.

Authors:  T L Fisher; J Blenis
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

9.  3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.

Authors:  D R Alessi; M Deak; A Casamayor; F B Caudwell; N Morrice; D G Norman; P Gaffney; C B Reese; C N MacDougall; D Harbison; A Ashworth; M Bownes
Journal:  Curr Biol       Date:  1997-10-01       Impact factor: 10.834

10.  The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain.

Authors:  R B Pearson; P B Dennis; J W Han; N A Williamson; S C Kozma; R E Wettenhall; G Thomas
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

View more
  128 in total

1.  RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2.

Authors:  Yuan Xiao Zhu; Hongwei Yin; Laura A Bruins; Chang-Xin Shi; Patrick Jedlowski; Meraj Aziz; Chris Sereduk; Klaus Martin Kortuem; Jessica E Schmidt; Mia Champion; Esteban Braggio; A Keith Stewart
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

Review 2.  Targeting protein kinases with selective and semipromiscuous covalent inhibitors.

Authors:  Rand M Miller; Jack Taunton
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

3.  Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain.

Authors:  D E Clark; C E Poteet-Smith; J A Smith; D A Lannigan
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

4.  Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis.

Authors:  Susumu Rokudai; Naoya Fujita; Osamu Kitahara; Yusuke Nakamura; Takashi Tsuruo
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

Review 5.  Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm.

Authors:  Alexandra C Newton
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

6.  Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells.

Authors:  Eran Silverman; Morten Frödin; Steen Gammeltoft; James L Maller
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B.

Authors:  Michael P Scheid; Paola A Marignani; James R Woodgett
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site.

Authors:  Ricardo M Biondi; David Komander; Christine C Thomas; Jose M Lizcano; Maria Deak; Dario R Alessi; Daan M F van Aalten
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

9.  Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation.

Authors:  Michael P Scheid; Michael Parsons; James R Woodgett
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25C.

Authors:  Eusebio Perdiguero; Marie-Jeanne Pillaire; Jean-Francois Bodart; Florian Hennersdorf; Morten Frödin; Nicholas S Duesbery; Gema Alonso; Angel R Nebreda
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.